Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease

Bhakti Mehta, Kris Mahadeo, Neena Kapoor, Hisham Abdel-Azim

Research output: Contribution to journalArticle

4 Scopus citations


HSCT with MAC is associated with durable donor engraftment for patients with CGD; however, MAC is limited by high rates of RRT. We used a novel RIC regimen with LD-TBI (200 cGy × two doses), fludarabine (30 mg/m2 × three doses), and proximal alemtuzumab (0.5 mg/kg/dose × one dose) and unrelated donor grafts for consecutive patients with high-risk CGD who were not candidates for MAC at our institution. Among four children with CGD transplanted at our institution, three PBSC recipients are alive with sustained donor engraftment (median follow-up: two yr) and resolution of pre-HSCT active infections while one patient with bone marrow graft is alive after graft failure and autologous recovery. RIC may be a curative option for children with high-risk CGD.

Original languageEnglish (US)
Pages (from-to)408-412
Number of pages5
JournalPediatric Transplantation
Issue number4
Publication statusPublished - Jun 1 2015



  • chronic granulomatous disease
  • hematopoietic stem cell transplantation
  • pediatric
  • reduced-intensity conditioning
  • unrelated donor

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this